Search research articles
Contact Us
Filters
Showing results (131-140 of 303) with videos related to
Page
of 31
Sort By:
Journal of Medical Virology
|
September 15, 2007
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences
Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
December 16, 2018
Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease
Chongye Fang, Xianbin Cai, Shuhei Hayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2006
Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
Wakaba Fukushima, Takashi Tanaka, Satoko Ohfuji, et al.
Oncology Letters
|
August 10, 2017
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Journal of Gastroenterology
|
March 18, 2014
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
Yoshiyuki Sakai, Yoshinori Iwata, Hirayuki Enomoto, et al.
Journal of Cancer
|
March 7, 2017
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 23, 2002
Changes in hypervariable region 1 in patients with chronic hepatitis C of genotype 1b with biochemical response to interferon
Shuhei Nishiguchi, Motoharu Tanaka, Susumu Shiomi, et al.
Journal of Cancer
|
March 1, 2017
Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
The American Journal of Gastroenterology
|
February 28, 2002
Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment
Masaru Enomoto, Shuhei Nishiguchi, Susumu Shiomi, et al.
Biochemical and Biophysical Research Communications
|
December 3, 2014
Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro
Chisa Kuga, Hirayuki Enomoto, Nobuhiro Aizawa, et al.
Page
of 31
Search research articles
Search
Showing results (131-140 of 303) with videos related to
Sort By:
Page
of 31
Journal of Medical Virology
|
September 15, 2007
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences
Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
December 16, 2018
Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease
Chongye Fang, Xianbin Cai, Shuhei Hayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2006
Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
Wakaba Fukushima, Takashi Tanaka, Satoko Ohfuji, et al.
Oncology Letters
|
August 10, 2017
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Journal of Gastroenterology
|
March 18, 2014
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
Yoshiyuki Sakai, Yoshinori Iwata, Hirayuki Enomoto, et al.
Journal of Cancer
|
March 7, 2017
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 23, 2002
Changes in hypervariable region 1 in patients with chronic hepatitis C of genotype 1b with biochemical response to interferon
Shuhei Nishiguchi, Motoharu Tanaka, Susumu Shiomi, et al.
Journal of Cancer
|
March 1, 2017
Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
The American Journal of Gastroenterology
|
February 28, 2002
Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment
Masaru Enomoto, Shuhei Nishiguchi, Susumu Shiomi, et al.
Biochemical and Biophysical Research Communications
|
December 3, 2014
Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro
Chisa Kuga, Hirayuki Enomoto, Nobuhiro Aizawa, et al.
Page
of 31